A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J. Angiolillo, Mark B. Effron, Brian Baker et al.|European Heart Journal|2011Cited by 182
The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology DataBaojin Zhu, Kenneth J. Winters, Mark B. Effron et al.|Journal of Cardiovascular Pharmacology|2011Cited by 20
Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)Dominick J. Angiolillo, Mark B. Effron, Juan J. Badimon et al.|Queensland's institutional digital repository (The University of Queensland)|2009Cited by 3
Abstract 4946: Comparison of Prasugel With Clopidogrel on Platelet Function in Coronary Artery Disease Patients With Type 2 Diabetes Mellitus - Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)Dominick J. Angiolillo, Mark B. Effron, Clement K. Ojeh et al.|Circulation|2009Cited by 2